miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs

BackgroundRecently, miR-10b is identified as a miRNA highly expressed in many human cancers, promoting cell migration and invasion. However, the specific function of miR-10b in hepatocellular carcinoma (HCC) is unclear at this point.MethodsThe miR-10b expression levels in 60 paired different TNM Stage HCC tumor tissues compared with adjacent non-tumor (ANT) tissues, normal tissue control (8 benign tumor and 7 normal liver tissues), 3 normal liver and 7 HCC cell lines were measured by real-time quantitative RT-PCR and to evaluate their association with HCC clinicopathologic features. Invasion assay, MTT proliferation assay and wound-healing assay were performed to test the invasion and proliferation of HCC cell after transfection. The effect of miR-10b on HCC in vivo was validated by murine xenograft model.ResultsWe found that miR-10b expression was increased in human HCC tissues and cell lines compared with normal control, respectively. The expression of miR-10b was correlated with HCC metastatic ability. Overexpression of miR-10b in MHCC-97L cells increased cell motility and invasiveness, whereas inhibition of miR-10b in MHCC-97H cells reduced cell motility and invasiveness in vitro and in vivo. We also showed that HOXD10 was negatively regulated by miR-10b at the posttranscriptional level, via a specific target site within the 3′UTR by luciferase reporter assay. Furthermore, we found that miR-10b induced HCC cell invasion and migration by modulating the HOXD10 target gene RhoC, uPAR, MMP-2 and MMP-9 expression.ConclusionsOur results suggested that miR-10b was overexpressed in HCC and promoted HCC cell migration and invasion through the HOXD10/ RhoC/ uPAR/ MMPs pathway which may provide a novel bio-target for HCC therapy.

[1]  W. Cong,et al.  Methylation of Tip30 Promoter Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma , 2008, Clinical Cancer Research.

[2]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[3]  Tian Yang,et al.  microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity , 2010, British Journal of Cancer.

[4]  C. Myers,et al.  Sustained expression of homeobox D10 inhibits angiogenesis. , 2002, The American journal of pathology.

[5]  [Overexpression of the RhoC gene correlates with invasion and metastasis of hepatocellular carcinoma]. , 2004, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[6]  Xin Wu,et al.  A specific splicing variant of SVH, a novel human armadillo repeat protein, is up-regulated in hepatocellular carcinomas. , 2003, Cancer research.

[7]  C. Croce,et al.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. , 2007, JAMA.

[8]  Liang Zhou,et al.  MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells , 2012, Tumor Biology.

[9]  Phillip D. Zamore,et al.  Ribo-gnome: The Big World of Small RNAs , 2005, Science.

[10]  Jin-Lin Hou,et al.  Hepatocellular carcinoma in the Asia pacific region , 2009, Journal of gastroenterology and hepatology.

[11]  Wen-Hsiu Hsu,et al.  Urokinase induces stromal cell‐derived factor‐1 expression in human hepatocellular carcinoma cells , 2012, Journal of cellular physiology.

[12]  Tushar Patel,et al.  Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.

[13]  T. Mak,et al.  RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. , 2005, Genes & development.

[14]  Kazuhiro Yoshida,et al.  Expression of RhoC Is Associated with Metastasis of Gastric Carcinomas , 2003, Pathobiology.

[15]  Shuomin Zhu,et al.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.

[16]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[17]  T. Kondoh,et al.  MicroRNA‐10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC , 2009, International journal of cancer.

[18]  S. Russell,et al.  Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor. , 2009, Cancer research.

[19]  C. Myers,et al.  Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. , 2005, Cancer research.

[20]  Zhihua Liu,et al.  MicroRNA-10b Promotes Migration and Invasion through KLF4 in Human Esophageal Cancer Cell Lines* , 2010, The Journal of Biological Chemistry.

[21]  Guan Sun,et al.  MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10 , 2011, Brain Research.

[22]  Hua Li,et al.  MicroRNA‐10b regulates tumorigenesis in neurofibromatosis type 1 , 2010, Cancer science.

[23]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[24]  Junxia Zhang,et al.  hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells , 2008, Brain Research.

[25]  Guanghai Yang,et al.  MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). , 2010, Clinica chimica acta; international journal of clinical chemistry.

[26]  Q. Pan,et al.  MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. , 2010, Cancer letters.

[27]  Eric S. Lander,et al.  Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.

[28]  Yi Tie,et al.  MicroRNA‐101 regulates expression of the v‐fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma , 2009, Hepatology.

[29]  Expression of Twist gene in human hepatocellular carcinoma cell strains of different metastatic potential , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[30]  Li Yan,et al.  Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes , 2007, American journal of hematology.

[31]  Young-Chae Chang,et al.  Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Lin Zhang,et al.  The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis , 2008, Nature Cell Biology.

[34]  Laura Pelletier,et al.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.

[35]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[36]  S. Merajver,et al.  RhoC GTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinomas of the Head and Neck , 2006, Clinical Cancer Research.

[37]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.